REQUEST A DEMO
Total
USD $0.00
Search more companies

Cytogen Inc. (South Korea)

Main Activities: Research and Development in Nanotechnology
Full name: Cytogen Inc. Profile Updated: June 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Cytogen Inc. is based in South Korea, with the head office in Seoul. It operates in the Research and Development in Nanotechnology industry. It was first established on March 18, 2010. There are currently 50 (2024) people employed by Cytogen Inc.. From the latest financial highlights, Cytogen Inc. reported a net sales revenue increase of 242.63% in 2024. Its’ total assets recorded a negative growth of 2.65%. The net profit margin of Cytogen Inc. increased by 338.34% in 2024.

Headquarters
8F, A-Dong, 128, Beopwon-Ro, Songpa-Gu
Seoul; Seoul;

Contact Details: Purchase the Cytogen Inc. report to view the information.

Website: http://cytogenlab.com

Basic Information
Total Employees:
Purchase the Cytogen Inc. report to view the information.
Outstanding Shares:
Purchase the Cytogen Inc. report to view the information.
Registered Capital:
Purchase the Cytogen Inc. report to view the information.
Financial Auditors:
Purchase the Cytogen Inc. report to view the information.
Incorporation Date:
March 18, 2010
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
20.1%
Purchase this report to view the information.
10.9%
Purchase this report to view the information.
2.6%
Subsidiaries
웰마커바이오 (주)
Company Performance
Financial values in the chart are available after Cytogen Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
242.63%
Total Operating Revenue
167.88%
Operating Profit
-0.32%
EBITDA
-17.22%
Net Profit/Loss for the Period
-8.54%
Total Assets
-2.65%
Total Equity
-8.27%
Operating Profit Margin
310.61%
Net Profit Margin
338.34%
Return on Equity (ROE)
-5.41%
Debt / Equity
-2556%
Quick Ratio
4623.16%
Cash Ratio
1.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?